Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

amicus brief

amicus brief

20 results

Filter Results By

Filter Applied. Clear All

Latest Posts

June 18, 2024 Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion June 3, 2024 Abortion Reporting: Arkansas (2023) Abortion Reporting: Arkansas (2023) May 29, 2024 Abortion Reporting: West Virginia (2023) Abortion Reporting: West Virginia (2023)
Reset All Filters
20 results
amicus brief

Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case

CLI recently filed an amicus brief in the case Moyle v. United States (consolidated with Idaho v. U.S.) to be considered before the Supreme Court this April. The Biden administration has interpreted the federal Emergency Medical Treatment and Labor Act in a way that would compel emergency room doctors to perform abortions even when a mother’s life is not in danger. According to CLI, such an interpretation of EMTALA is incoherent and in conflict with the plain sense of the text.

charlotte-lozier-institute Charlotte Lozier Institute
March 25, 2024
ClosePlease login
amicus brief

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepristone is not "safe," that the FDA's loosening of mifepristone regulations makes these safety concerns even worse, and that AHM et al. have standing, since they would suffer concrete injury under the current loosened mifepristone regulations, being at risk of finding themselves complicit in abortion procedures.

featured-image
amicus brief

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs

As the nation’s leading pro-life scientific, statistical and research center, the Charlotte Lozier Institute has filed an amicus brief asking the Supreme Court to affirm the 5th U.S. Circuit Court of Appeals decision that found the FDA likely violated the law when it loosened safeguards on abortion drugs by allowing them to be sent by mail.

featured-image
amicus brief

Filed Brief: Zurawski v. Texas and Reasonable Medical Judgment

In February 2024, CLI filed a joint amicus brief with the Alliance for Hippocratic Medicine supporting Texas in the case Zurawski v. State of Texas. The state’s abortion law is challenged on the grounds that its medical emergency exception is unduly vague, leaving physicians confused and unable to properly intervene to help pregnant women. Texas and CLI/AHM, however, argue that the “reasonable medical judgment” standard for when doctors are justified in intervening to save a mother’s life or major bodily function is both legally and medically sound. CLI and AHM agree with Texas, and expand on why their position is justified in this brief submitted to the court.

featured-image
amicus brief

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to the Constitutional Court of Ecuador. This brief was written in support of three provisions of Ecuador’s Organic Law Regulating the Voluntary Interruption of Pregnancy: (1) a requirement that ultrasounds be performed prior to abortion decisions, (2) a 12-week gestational age limit on abortion, and (3) a prohibition on the commodification of post-abortion fetal remains. Following is CLI’s amicus brief reproduced in full.

featured-image
amicus brief

Response to Media Allegations that Abortion Restrictions Cause Maternal Mortality and Female Suicides

Each concern regarding abortion restrictions and maternal health is addressed below from an evidence-based perspective, followed by a rebuttal to the most recent claims in the media.

featured-image
amicus brief

Does Abortion Improve Economic Outcomes for Women? A Review of the Evidence

This paper explores the research literature and the basis for this claim that abortion economically benefits women, whether it is verifiable, poses some questions and critiques, and offers insights into the economic consequences of abortion for both women and men.

amicus brief

Scientists Ask U.S. District Court to Suspend Sale of Dangerous, Poorly Tested Abortion Pills

With major international studies showing that the abortion pill regimen carries four times the risk of complications as surgical abortion, Charlotte Lozier Institute has filed an amicus brief asking the U.S. District Court for the Northern District of Texas to grant a preliminary injunction suspending the Food and Drug Administration’s (FDA) approval of the abortion pill. 

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image